Fredun-Pharmaceuticals (2)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE lists 1,06,668 new equity shares of Fredun Pharmaceuticals Limited issued to promoters on preferential basis via warrant conversion, … | |||||||||||||||
BSE lists 1,06,668 new equity shares of Fredun Pharmaceuticals Limited issued to promoters on preferential basis via warrant conversion, effective May 4, 2026.
| |||||||||||||||
BSE notifies listing and trading permission for 6,44,360 new equity shares of Fredun Pharmaceuticals Limited issued on preferential basis to … | |||||||||||||||
BSE notifies listing and trading permission for 6,44,360 new equity shares of Fredun Pharmaceuticals Limited issued on preferential basis to non-promoters, effective March 4, 2026. Shares are subject to lock-in until September 15, 2026.
| |||||||||||||||